DEM Biopharma is a privately held, Cambridge, MA based pre-IND stage biopharmaceutical company dedicated to discovering novel therapeutic targets for solid tumors
DEM Biopharma is a privately held, Cambridge, MA based pre-IND stage biopharmaceutical company dedicated to discovering novel therapeutic targets for solid tumors. Our innovative platform enables us to identify unique strategies to attack tumor cells and the tumor microenvironment (TME).